OncoveryCare Partners with Tennessee Oncology and Raises $4.5M Seed Round from .406 VenturesThe company is radically redefining the care model for cancer survivorshipBOSTON, Mass., May 23, 2024-- OncoveryCare (formerly VivorCare) has closed an oversubscribed $4.5 million seed financing to launch its novel cancer survivorship care model.

OncoveryCare与田纳西州肿瘤学合作，从406 Ventures筹集了450万美元的种子资金。该公司正在彻底重新定义癌症幸存者的护理模式。2024年5月23日，马萨诸塞州波士顿——OncoveryCare（原VivorCare）已关闭了一笔450万美元的超额认购种子资金，以推出其新型癌症幸存者护理模式。

The fundraise was led by .406 Ventures alongside the McKay Institute for Oncology Transformation at Tennessee Oncology. Tennessee Oncology, which treats half of Tennessee's cancer patients at 35 clinical sites of care, is also a founding member of OneOncology, a fast-growth oncology platform dedicated to supporting independent oncology practices through capital, technology and expertise.

此次募资由田纳西州肿瘤学的麦凯肿瘤学转化研究所（McKay Institute for Oncology Transformation）和0.406家企业共同牵头。田纳西肿瘤学（Tennessee Oncology）在35个临床护理点治疗田纳西州一半的癌症患者，也是OneOncology的创始成员，OneOncology是一个快速发展的肿瘤学平台，致力于通过资本、技术和专业知识支持独立的肿瘤学实践。

Additional investors in the round include Oncology Ventures and Techstars. Along with the financing, OncoveryCare also announced a partnership with Tennessee Oncology, which will allow the company to offer its care model to patients across Tennessee..

本轮投资的其他投资者包括肿瘤学风险投资公司（OncologyVentures）和Techstars。除此之外，OncoveryCare还宣布与田纳西州肿瘤学公司建立合作关系，这将使该公司能够为田纳西州的患者提供其护理模式。。

The population of cancer survivors is growing rapidly in the US (expecting to double between 2008 and 2030 to 22 million) due to both the rising incidence of the disease and lower mortality rates from advances in treatment. Cancer survivors can face significant challenges after active cancer treatment, including cardiotoxicity and cancer-related fatigue; complex screening and monitoring protocols; and anxiety and depression linked to cancer diagnosis and treatment.

由于癌症发病率的上升和治疗进展导致的死亡率下降，美国癌症幸存者的人数正在迅速增长（预计在2008年至2030年期间将翻一番，达到2200万）。癌症幸存者在积极的癌症治疗后可能面临重大挑战，包括心脏毒性和癌症相关的疲劳；复杂的筛选和监测协议；焦虑和抑郁与癌症的诊断和治疗有关。

Despite these growing needs, there is a gap in the cancer care continuum: the management of survivorship remains fragmented, unstructured, and reliant on an overburdened oncology workforce, which leads to high costs and poor outcomes. OncoveryCare will fill this survivorship gap..

尽管需求不断增长，但癌症护理连续体仍存在差距：幸存者的管理仍然支离破碎，无组织，并且依赖于负担过重的肿瘤学劳动力，这导致了高成本和不良结果。OncoveryCare将填补这一幸存者缺口。。

'Survivorship is the next frontier in cancer care delivery,' explained Hil Moss, Co-founder and Chief Executive Officer of OncoveryCare, whose own experience as a breast cancer survivor motivated her to launch the company. 'For decades we have been focused on finding the cure for cancer. Now we have to answer the question: what happens when people survive?'.

OncoveryCare联合创始人兼首席执行官希尔·莫斯（HilMoss）解释说：“幸存者是癌症护理服务的下一个前沿领域，她自己作为乳腺癌幸存者的经历促使她创办了这家公司。”几十年来，我们一直专注于寻找治疗癌症的方法。现在我们必须回答这个问题：当人们生存下来时会发生什么。

Dr. Justin Grischkan, Co-founder and Chief Medical Officer, shared that there is a need for a fundamentally new approach to survivorship care: 'Cancer survivors face a unique set of clinical challenges that stem from cancer treatment, which can impact both mental and physical health. We are building a comprehensive care model to intervene on the short- and long-term effects of a cancer diagnosis.'.

联合创始人兼首席医疗官贾斯汀·格里斯坎博士（JustinGrischkan）表示，需要一种全新的生存护理方法：“癌症幸存者面临着一系列独特的临床挑战，这些挑战源于癌症治疗，可能会影响身心健康。我们正在建立一个全面的护理模式，以干预癌症诊断的短期和长期影响。”。

OncoveryCare is launching with a virtual care model for cancer survivorship, equipping patients with a wraparound care team of survivorship-trained clinicians. Initial areas of focus include toxicity management, mental health support, navigation and care planning, and preventative care. To bring this new model to life, OncoveryCare is partnering with the McKay Institute-the dedicated innovation arm of Tennessee Oncology, one of the nation's largest community-based cancer care specialists-to scale the intervention across Tennessee Oncology's survivor population with the goal of expanding to the oncology world at large..

OncoveryCare推出了一种针对癌症幸存者的虚拟护理模式，为患者配备了一支由经过幸存者培训的临床医生组成的综合护理团队。最初的重点领域包括毒性管理，心理健康支持，导航和护理计划以及预防保健。为了将这种新模式付诸实践，OncoveryCare正在与麦凯研究所（McKay Institute）合作，麦凯研究所是田纳西州肿瘤学（Tennessee Oncology）的专门创新机构，该机构是美国最大的社区癌症护理专家之一，旨在扩大田纳西州肿瘤学幸存者的干预范围，目标是扩大到整个肿瘤学世界。。

'Through the McKay Institute, we aim to bring new ideas into our organization, bolstering technologies, innovations, and leadership crucial for the evolution of oncology care. Teaming up with OncoveryCare, we will provide the necessary clinical infrastructure and leadership support to advance this cutting-edge care delivery model,' said Natalie Dickson, MD, Chief Executive Officer at Tennessee Oncology..

“通过麦凯研究所，我们的目标是为我们的组织带来新的想法，支持对肿瘤护理发展至关重要的技术，创新和领导力。田纳西州肿瘤学首席执行官纳塔莉·迪克森（NatalieDickson）医学博士说，与OncoveryCare合作，我们将提供必要的临床基础设施和领导支持，以推进这一尖端护理模式。。

This Seed financing, led by .406 Ventures, will enable OncoveryCare to continue growing its care delivery model, as well as develop novel tools and approaches to scale access to high-quality survivorship care more broadly. 'We had a longstanding thesis in the cancer survivorship space and had been searching for a company that addresses the meaningful and costly challenges that cancer survivors face,' said Payal Agrawal Divakaran, Partner at .406 Ventures.

这项由406家风险投资公司牵头的种子融资将使OncoveryCare能够继续发展其护理服务模式，并开发新的工具和方法，以更广泛地扩大获得高质量生存护理的机会。”406 Ventures合伙人帕亚尔·阿格拉瓦尔·迪瓦卡兰（PayalAgrawalDivakaran）说：“我们在癌症幸存者领域有一个长期的论题，一直在寻找一家能够解决癌症幸存者面临的有意义且代价高昂的挑战的公司。”。

'Hil and Justin's deep understanding of the problem has allowed them to build a thoughtful and comprehensive solution, and they have found an ideal launch partner in Tennessee Oncology.'.

“希尔和贾斯汀对这个问题的深刻理解使他们能够建立一个深思熟虑和全面的解决方案，并且他们在田纳西州肿瘤学领域找到了一个理想的启动合作伙伴。”。

About OncoveryCare

关于OncoveryCare

OncoveryCare delivers comprehensive, whole-person care to cancer survivors. As the population of survivors grows rapidly alongside advances in medicine, OncoveryCare provides the personalized, longitudinal care that cancer survivors need to lead happier, healthier lives. Founded by a breast cancer survivor and led by both clinicians and survivors, OncoveryCare's first offering is a novel Cancer Transitions of Care program, equipping each survivor with a survivorship-trained clinical team and the essential tools and skills they need to actively manage their survivorship journey.

OncoveryCare为癌症幸存者提供全面的全人护理。随着幸存者人数的迅速增长以及医学的进步，OncoveryCare提供了癌症幸存者需要的个性化纵向护理，以过上更快乐，更健康的生活。OncoveryCare由一名乳腺癌幸存者创建，由临床医生和幸存者共同领导，它的第一项服务是一项新型的癌症过渡护理计划，为每位幸存者配备了一支经过幸存者培训的临床团队，以及他们积极管理其幸存者旅程所需的基本工具和技能。

Learn more at www.oncoverycare.com, and follow us on LinkedIn and Instagram @oncoverycare..

请访问www.oncoverycare.com了解更多信息，并在LinkedIn和Instagram@oncoverycare上关注我们。。

About .406 Ventures

约406家企业

.406 Ventures is a Boston-based venture capital firm with over $1.4B under management and nearly two decades of experience leading or co-leading early-stage investments in pioneering healthcare, data + AI, and cybersecurity companies founded by visionary entrepreneurs. Notable lead investments include AbleTo (acquired by Optum), Carbon Black (acquired by VMWare), Cloud Health (acquired by VMware), Corvus (acquired by Travelers), Health Dialog (acquired by BUPA), Iora Health (acquired by One Medical/Amazon), Mineral Tree (acquired by Global Payments), and Veracode (acquired by CA Technologies).

.406 Ventures是一家总部位于波士顿的风险投资公司，管理资金超过14亿美元，拥有近20年的经验，领导或共同领导由有远见的企业家创办的开创性医疗保健、数据+人工智能和网络安全公司的早期投资。值得注意的主要投资包括AbleTo（被Optum收购）、炭黑（被VMWare收购）、Cloud Health（被VMWare收购）、Corvus（被Travelers收购）、Health Dialog（被BUPA收购）、Iora Health（被One Medical/Amazon收购）、Mineral Tree（被Global Payments收购）和Veracode（被CA Technologies收购）。

Learn more at 406ventures.com and follow us on LinkedIn and X..

请访问406ventures.com了解更多信息，并在LinkedIn和X上关注我们。。

About Tennessee Oncology

关于田纳西州肿瘤学

Tennessee Oncology, one of the nation's largest community-based cancer care practices, is home to one of the leading clinical trial networks in the country. Established 1976 in Nashville, Tennessee Oncology's mission remains unchanged: To provide access to high-quality cancer care and the expertise of clinical research for all patients, at convenient locations within their community and close to their home.

田纳西州肿瘤学是美国最大的基于社区的癌症护理实践之一，是该国领先的临床试验网络之一的所在地。田纳西州肿瘤学于1976年在纳什维尔成立，其使命保持不变：在社区内和离家近的方便地点，为所有患者提供高质量的癌症护理和临床研究专业知识。

Our growing network of physicians and locations is based on this mission. For more information, visit www.tnoncology.com.Contact: .

我们不断增长的医生和地点网络正是基于这一使命。有关更多信息，请访问www.tnoncology.com.Contact：。。

Nina Pfister, MAG PR

尼娜·普菲斯特（Nina Pfister），MAG PR

E: nina@mooringadvisorygroup.com

Enina@mooringadvisorygroup.com

T: 781-929-5620

T： 781-929-5620